Cyteir Therapeutics, Inc.
CYT · NASDAQ
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $102,327 | $92,933 | $64,770 | $58,370 |
| - Cash | $129,242 | $133,635 | $137,204 | $147,120 |
| + Debt | $16 | $57 | $98 | $889 |
| Enterprise Value | -$26,899 | -$40,645 | -$72,336 | -$87,861 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$100 | -$100 | -$308 | -$326 |
| % Margin | – | – | – | – |
| EBITDA | -$5,061 | -$9,499 | -$13,422 | -$8,658 |
| % Margin | – | – | – | – |
| Net Income | -$3,532 | -$8,404 | -$11,550 | -$7,398 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.098 | -0.24 | -0.32 | -0.21 |
| % Growth | 59.2% | 25% | -52.4% | – |
| Operating Cash Flow | -$4,556 | -$4,149 | -$10,167 | -$6,917 |
| Capital Expenditures | $0 | $0 | $0 | -$302 |
| Free Cash Flow | -$4,556 | -$4,149 | -$10,167 | -$7,219 |